The relationship between cell-free circulating DNA and inflammation in acute coronary syndrome

Cardiology (Switzerland)

Volumn 126, Issue 2, 2013, Pages 124-125

  Cui, Ming ^a   Jing, Rongrong ^a   Fan, Mengkang ^a   Zhu, Jianhua ^a   Ju, Shaoqing ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CELL FREE CIRCULATING DNA; CYTOKINE; DNA; HOMOCYSTEINE; MITOCHONDRIAL DNA; TOLL LIKE RECEPTOR 9; TROPONIN T; UNCLASSIFIED DRUG; VASCULOTROPIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; APOPTOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; HEPATITIS; HUMAN; INFLAMMATION; LETTER; LIVER NECROSIS; NONALCOHOLIC FATTY LIVER; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SLEEP DISORDERED BREATHING; STABLE ANGINA PECTORIS; THORAX PAIN;

ACUTE CORONARY SYNDROME; DNA; FEMALE; HUMANS; MALE;

EID: 84885065498     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000353665     Document Type: Letter

References (14)

1. Balta S, Demirkol S, Cakar M, Karaman M, Ay SA, Arslan Z: Cell-free circulating DNA as a novel biomarker in patients with acute coronary syndrome. Cardiology 2013;126:122-123.
2. Wang E, Batey A, Struble C, Musci T, Song K, Oliphant A: Gestational age and maternal weight effects on fetal cfDNA in maternal plasma. Prenat Diagn 2013; 2: 1-5.
3. Chen Z, Fadiel A, Naftolin F, Eichenbaum KD, Xia Y: Circulation DNA: biological implications for cancer metastasis and immunology. Med Hypotheses 2005; 65: 956-961.
4. Jylh?v? J, Nevalainen T, Marttila S, Jylh? M, Hervonen A, Hurme M: Characterization of the role of distinct plasma cell-free DNA species in age-associated inflammation and frailty. Aging Cell 2013; 12: 388-397.
5. Simpson JL: Cell-free fetal DNA and maternal serum analytes for monitoring embryonic and fetal status. Fertil Steril 2013; 99: 1124-1134.
6. Jing R, Cui M, Wang H, Ju S: Cell-free DNA: characteristics, detection and its applications in myocardial infarction. Curr Pharm Des 2013; 19: 5135-5145.
7. Li Y, Hai J, Li L, Chen X, Peng H, Cao M, Zhang Q: Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development. Endocrine 2013; 43: 376-386.
8. Ye L, Ma GH, Chen L, Li M, Liu JL, Yang K, Li QY, Li N, Wan HY: Quantification of circulating cell-free DNA in the serum of patients with obstructive sleep apnea-hypopnea syndrome. Lung 2010; 188: 469-474.
9. Hochholzer W, Reichlin T, Twerenbold R, Stelzig C, Hochholzer K, Meissner J, Haaf P, Schaub N, Steuer S, Bassetti S, Reiter M, Roost K, Freidank H, Winkler K, Mueller C: Incremental value of high-sensitivity cardiac troponin T for risk prediction in patients with suspected acute myocardial infarction. Clin Chem 2011; 57: 1318-1326.
10. Rainer TH, Lam NY, Man CY, Chiu RW, Woo KS, Lo YM: Plasma beta-globin DNA as a prognostic marker in chest pain patients. Clin Chim Acta 2006; 368: 110-113.
11. Sibbing D, Bernlochner I, Schulz S, Massberg S, Schömig A, Mehilli J, Kastrati A: The impact of smoking on the antiplatelet action of clopidogrel in non-ST-elevation myocardial infarction patients: results from the ISAR-REACT 4 Platelet Substudy. J Thromb Haemost 2012; 10: 2199-2202.
12. Okazaki S, Furukado S, Abe Y, Tanaka M, Miwa K, Yamagami H, Sakaguchi M, Sakoda S, Kitagawa K: Association of inflammatory markers and carotid intima-media thickness with the risk of cardiovascular events in highrisk patients. Cerebrovasc Dis 2010; 30: 180-187.
13. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ: Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464: 104-107.
14. Chen C, Xu J, Huang F: Recent players in the field of acute myocardial infarction biomarkers: circulating cell-free DNA or microRNAs? Int J Cardiol 2013, E-pub ahead of print.